There is Hope. The Hope Heart Institute is committed to serving humanity through cardiovascular research and education. We are dedicated to preventing and treating heart and blood vessel disease, and to improving the physical, emotional and spiritual quality of life for all at risk of – or affected by – cardiovascular disease.
Facts & Figures | At a Glance
# of Research Coordinators | 3
# of Active Principal Investigators | 11
# of Regulatory & Contract staff | 1
Medical Director | James Leggett, MD, FACC
Types of Research: FDA-approved and non-approved drugs and devices.
Research Study Areas: Acute Coronary Syndrome | Acute MI | Atrial Fibrillation | Carotid Stenting | Coronary Artery Disease & Lipid Therapies | Coronary Stenting | Heart Failure | Hypertension | Novel Heart Failure Device Therapies | Pacing & Cardiac Resynchronization Therapy | Renal Artery Disease
Investigators: Our experienced team of investigators provides oversight on many areas of cardiovascular research, conducting meaningful and vital studies that will impact prevention and treatment for existing patients as well as generations to come.
Staff: Our informed and driven clinical staff is dedicated to the Hope Heart Clinical Research Program vision. Our diverse team of experienced research professionals works directly with our investigators to conduct research that is in line with The Hope’s commitment to cardiovascular outreach, education, and research.
Affiliated Hospitals and Clinics: Overlake Hospital Medical Center | Overlake Medical Clinics Cardiology | Overlake Internal Medicine Associates
Contact: For more information contact us at